Motor function improvement after intravenous pamidronate in osteoporosis pseudoglioma syndrome

Journal of Pediatrics

Volumn 149, Issue 5, 2006, Pages 734-

  Di Iorgi, Natascia ^a   Maghnie, Mohamad ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PAMIDRONIC ACID;

AUTOSOMAL RECESSIVE DISORDER; BONE DENSITY; BONE MALFORMATION; CASE REPORT; CHILD; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DISEASE SEVERITY; DRUG RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; GENE MUTATION; HUMAN; LABORATORY TEST; LETTER; MALE; MOTOR PERFORMANCE; OSTEOPOROSIS; OSTEOPOROSIS PSEUDOGLIOMA SYNDROME; PRIORITY JOURNAL; RETINOBLASTOMA;

ACTIVITIES OF DAILY LIVING; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; INFUSIONS, INTRAVENOUS; MOVEMENT; OSTEOGENESIS IMPERFECTA; WALKING;

EID: 33750609620     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.06.069     Document Type: Letter

References (3)

1. Land C., Rauch F., Montpetit K., Ruck-Gibis J., and Glorieux F.H. Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta. J Pediatr 148 (2006) 456-460
2. Schoenau E. From mechanostat theory to development of the "Functional Muscle-Bone-Unit". J Musculoskelet Neuronal Interact 5 (2005) 232-238
3. Gong Y., Slee R.B., Fukai N., Rawadi G., Roman-Roman S., Reginato A.M., et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107 (2001) 513-523